Search research articles
Contact Us
Filters
Showing results (151-160 of 193) with videos related to
Page
of 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 2020
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
L Zhang, F Zhu, L Xie, et al.
Oncogene
|
November 17, 2015
EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop
C-F Yang, G-D Yang, T-J Huang, et al.
Clinical Lung Cancer
|
October 11, 2024
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol
J Spicer, N Blais, S Owen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
G Giaccone, L A Bazhenova, J Nemunaitis, et al.
ESMO Open
|
February 17, 2026
Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)
K He, P M Forde, R Govindan, et al.
Scientific Reports
|
March 5, 2025
Spontaneous evolution of density peaking factor in TEM turbulence-dominated H-mode plasma on the EAST Tokamak
J S Geng, P Li, Y D Li, et al.
ESMO Open
|
February 12, 2022
Consensus for HER2 alterations testing in non-small-cell lung cancer
S Ren, J Wang, J Ying, et al.
ESMO Open
|
April 23, 2022
Corrigendum to 'Consensus for HER2 Alterations Testing in Non-small Cell Lung Cancer': [ESMO Open Volume 7 Issue 1 (2022) 100395]
S Ren, J Wang, J Ying, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study
F de Marinis, T M Kim, L Bonanno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2020
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma
G Lin, C Li, P S Li, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 193) with videos related to
Sort By:
Page
of 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 2020
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
L Zhang, F Zhu, L Xie, et al.
Oncogene
|
November 17, 2015
EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop
C-F Yang, G-D Yang, T-J Huang, et al.
Clinical Lung Cancer
|
October 11, 2024
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol
J Spicer, N Blais, S Owen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
G Giaccone, L A Bazhenova, J Nemunaitis, et al.
ESMO Open
|
February 17, 2026
Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung)
K He, P M Forde, R Govindan, et al.
Scientific Reports
|
March 5, 2025
Spontaneous evolution of density peaking factor in TEM turbulence-dominated H-mode plasma on the EAST Tokamak
J S Geng, P Li, Y D Li, et al.
ESMO Open
|
February 12, 2022
Consensus for HER2 alterations testing in non-small-cell lung cancer
S Ren, J Wang, J Ying, et al.
ESMO Open
|
April 23, 2022
Corrigendum to 'Consensus for HER2 Alterations Testing in Non-small Cell Lung Cancer': [ESMO Open Volume 7 Issue 1 (2022) 100395]
S Ren, J Wang, J Ying, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study
F de Marinis, T M Kim, L Bonanno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2020
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma
G Lin, C Li, P S Li, et al.
Page
of 20